共 9 条
[2]
Ferroportin 1 but not hephaestin contributes to iron accumulation in a cell model of Parkinson's disease[J] . Ning Song,Jun Wang,Hong Jiang,Junxia Xie. Free Radical Biology and Medicine . 2009 (2)
[3]
Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation[J] . Jun Peng,Fang Feng Stevenson,May Lin Oo,Julie K. Andersen. Free Radical Biology and Medicine . 2008 (2)
[4]
Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP + )-induced apoptosis in MES23.5 cells[J] . Shuzhen Zhang,Jun Wang,Ning Song,Junxia Xie,Hong Jiang. Neurobiology of Aging . 2007 (9)
[5]
Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells[J] . Hua-Min Xu,Hong Jiang,Jun Wang,Bing Luo,Jun-Xia Xie. Neurochemistry International . 2007 (6)
[7]
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases[J] . Moussa B.H. Youdim,Mati Fridkin,Hailin Zheng. Mechanisms of Ageing and Development . 2004 (2)
[8]
The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease[J] . B. Mirza,H. Hadberg,P. Thomsen,T. Moos. Neuroscience . 1999 (2)
[9]
Ferroportin1 and hephaestin are involved in the nigral iron accumulation of 6-OHDA-lesioned rats .2 Jun Wang,Hong Jiang,Jun-Xia Xie. European Journal of Neuroscience . 2007